相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities
Wing-Yu Fu et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease
Hsueh-Te Lee et al.
JOURNAL OF NEUROINFLAMMATION (2019)
P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection
Xuehong Liu et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Heme Oxygenase 1 Induces Tau Oligomer Formation and Synapse Aberrations in Hippocampal Neurons
Zizhen Si et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Neuroprotective effects of epoxyeicosatrienoic acids
Lai Wang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2018)
THE AMYLOID HYPOTHESIS ON TRAIL
Simon Makin
NATURE (2018)
Inflammasome signalling in brain function and neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease
Eric Tonnies et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Tracing investment in drug development for Alzheimer diseasemissing
Alpha Tom Kodamullil et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
ER stress and the unfolded protein response in neurodegeneration
Claudio Hetz et al.
NATURE REVIEWS NEUROLOGY (2017)
SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions
Ichiro Akiguchi et al.
NEUROPATHOLOGY (2017)
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
Karen M. Wagner et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors
Bora Inceoglu et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2017)
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro et al.
ALZHEIMERS & DEMENTIA (2016)
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence
Christian Grinan-Ferre et al.
EXPERIMENTAL GERONTOLOGY (2016)
Single administration of soluble epoxide hydrolase inhibitor suppresses neuroinflammation and improves neuronal damage after cardiac arrest in mice
Noriko Taguchi et al.
NEUROSCIENCE RESEARCH (2016)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
The promise and peril of chemical probes
Cheryl H. Arrowsmith et al.
NATURE CHEMICAL BIOLOGY (2015)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern
Annika I. Ostermann et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice
Soumee Bhattacharya et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
Christophe Morisseau et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Evidence for Early Cognitive Impairment Related to Frontal Cortex in the 5XFAD Mouse Model of Alzheimer's Disease
Stephane D. Girard et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Deciphering the mechanism underlying late-onset Alzheimer disease
Dimitrije Krstic et al.
NATURE REVIEWS NEUROLOGY (2013)
Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine
Min Ma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single- and Multiple-Dose Studies in Healthy Human Subjects
Dawn Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease
Kazuma Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
C. Corona et al.
CELL DEATH & DISEASE (2011)
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
Tristan E. Rose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Hans Zempel et al.
JOURNAL OF NEUROSCIENCE (2010)
Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model
Ryoichi Kimura et al.
NEUROBIOLOGY OF DISEASE (2009)
Senescence-Accelerated Mouse (SAM) with Special References to Neurodegeneration Models, SAMP8 and SAMP10 Mice
Toshio Takeda
NEUROCHEMICAL RESEARCH (2009)
DISTRIBUTION OF SOLUBLE AND MICROSOMAL EPOXIDE HYDROLASE IN THE MOUSE BRAIN AND ITS CONTRIBUTION TO CEREBRAL EPOXYEICOSATRIENOIC ACID METABOLISM
A. Marowsky et al.
NEUROSCIENCE (2009)
Distribution and expression of soluble epoxide hydrolase in human brain
Priyanka Sura et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Orally bioavailable potent soluble epoxide hydrolase inhibitors
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
Solomon S. Shaftel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Antibody to amyloid β protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice
JE Morley et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2002)
分享论文
